BIOMARIN PHARMACEUTICAL INC (BMRN) Stock Balance Sheet
NASDAQ:BMRN - US09061G1013 - Common Stock
58.58 USD
+0.51 (+0.88%)
58.58 USD
0 (0%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 817.25M | N/A | N/A | N/A | N/A | |||
| Cash Equivalents | 396.56M | 613.22M | 499.48M | 724.50M | 587.30M | |||
| Marketable Securities | 218.31M | 194.86M | 344.65M | 567.00M | 426.60M | |||
| Receivables | 855.86M | 660.53M | 633.70M | 461.30M | 373.40M | |||
| Inventories | 1.34B | 1.23B | 1.11B | 894.10M | 776.70M | |||
| Other Current Assets | 177.18M | 201.53M | 141.39M | 104.50M | 110.40M | |||
| Total Current Assets | 3.81B | 3.23B | 2.96B | 2.75B | 2.27B | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.03B | 1.08B | 1.11B | 1.11B | 1.08B | |||
| Investments And Advances | 508.59M | 527.84M | 622.43M | 333.80M | 507.80M | |||
| Goodwill | 196.20M | 196.20M | 196.20M | 196.20M | 196.20M | |||
| Intangibles | 239.62M | 255.28M | 294.70M | 338.60M | 388.70M | |||
| Other Non-Current Assets | 1.68B | 1.70B | 1.66B | 1.64B | 1.55B | |||
| Total Non-Current Assets | 3.65B | 3.76B | 3.89B | 3.62B | 3.73B | |||
| TOTAL ASSETS | 7.46B | 6.99B | 6.84B | 6.38B | 6.00B | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | 341.00K | 494.02M | 2.30M | 2.30M | |||
| Accrued Expenses | 311.69M | 351.07M | 322.84M | 317.80M | 277.10M | |||
| Accounts Payable | 310.80M | 235.40M | 315.51M | 231.20M | 193.00M | |||
| Other Current Liabilities | 61.76M | 20.17M | 44.66M | 37.50M | 67.50M | |||
| Total Current Liabilities | 684.25M | 606.99M | 1.18B | 588.90M | 539.80M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 596.16M | 595.89M | 593.17M | 1.08B | 1.08B | |||
| Deferred Taxes/Income | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Liabilities | 148.82M | 128.07M | 119.86M | 99.80M | 111.70M | |||
| Total Non-Current Liabilities | 744.98M | 723.96M | 713.03M | 1.18B | 1.19B | |||
| TOTAL LIABILITIES | 1.43B | 1.33B | 1.89B | 1.77B | 1.73B | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | 231.52M | -194.69M | -621.55M | -789.20M | -925.70M | |||
| Additional Paid In Capital | 5.85B | 5.80B | 5.61B | 5.40B | 5.19B | |||
| Common Shares | 192.00K | 191.00K | 189.00K | 200.00K | 200.00K | |||
| Other Shareholders' Equity | -59.47M | 48.60M | -39.52M | -600.00K | 6.10M | |||
| Shares Outstanding | 192.00M | 190.76M | 188.60M | 186.30M | 183.90M | |||
| Tangible Book Value per Share | 29.12 | 27.29 | 23.65 | 21.84 | 20.04 | |||
| Total Shareholders' Equity | 6.03B | 5.66B | 4.95B | 4.60B | 4.27B | |||
| TOTAL LIABILITIES AND EQUITY | 7.46B | 6.99B | 6.84B | 6.38B | 6.00B | |||
| Statistics | ||||||||
| Debt/Equity | 0.10 | 0.11 | 0.12 | 0.24 | 0.25 | |||
| Current Ratio | 5.56 | 5.33 | 2.51 | 4.67 | 4.21 | |||
| Return On Assets (ROA) | 8.81% | 6.11% | 2.45% | 2.22% | -1.07% | |||
| Return On Equity (ROE) | 10.90% | 7.54% | 3.39% | 3.08% | -1.50% | |||
| Return On Invested Capital (ROIC) | 10.27% | 7.49% | 2.75% | 0.94% | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | 11.30% | 8.58% | 3.23% | 1.21% | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | 12.16% | 9.33% | 3.60% | 1.37% | N/A | |||
All data in USD , ROIC based on taxRate of 0.16